🟢 Cresco Labs is trading 5% up today after closing $50 million Pennsylvania dispensary deal

Cresco Labs is trading 5.12% up now at $0.78 after announcing the closing of its Pennsylvania acquisition from PharmaCann.

• The September 2, 2026 closing covers nine Pennsylvania medical marijuana dispensaries acquired for $50 million.
• The company expects the transaction to be immediately accretive to revenue, margins, and cash flow.
• It strengthens Cresco Labs’ position in Pennsylvania’s medical cannabis market and is the clearest catalyst behind today’s gain.